Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH

Journal of Endocrinology

Volumn 214, Issue 3, 2012, Pages 367-372

  Abrahams, Lianne ^a   Semjonous, Nina M ^a   Guest, Phil ^a   Zielinska, Agnieszka ^a   Hughes, Beverly ^a   Lavery, Gareth G ^a   Stewart, Paul M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; BIOLOGICAL MARKER; CORTICOSTERONE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADRENAL HYPERPLASIA; ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME INHIBITION; FEMALE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; URINALYSIS; WILD TYPE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADRENAL GLANDS; ADRENAL HYPERPLASIA, CONGENITAL; ANIMALS; BIOLOGICAL MARKERS; CARBOHYDRATE DEHYDROGENASES; CORTICOSTERONE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, KNOCKOUT; ORGAN SIZE; PITUITARY-ADRENAL SYSTEM; SEX CHARACTERISTICS; STEROIDS;

EID: 84866303279     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0178     Document Type: Article

References (34)

1. Agarwal AK, Monder C, Eckstein B & White PC. 1989 Cloning and expression of rat cDNA encoding corticosteroid 11β-hydroxysteroid dehydrogenase. Journal of Biological Chemistry 264 18939-18943.
2. Alberts P, Nilsson C, Selen G, Engblom LOM, Edling NHM, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M et al. 2003 Selective Inhibition of 11B-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144 4755-4762.
3. Atanasov AG, Nashev LG, Gelman L, Legeza B, Sack R, Portmann R & Odermatt A. 2008 Direct protein-protein interaction of 11B-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783 1536-1543.
4. Boyle CD & Kowalski TJ. 2009 11β-Hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents. Expert Opinion on Therapeutic Patents. 19 801-825.
5. Bujalska IJ, Tomlinson JW, Draper N,Walker EA & Stewart PM. 2005 Hexose 6 phosphate dehydrogenase confers reductase activity upon 11B-HSD1. Endocrine Abstracts 7 219.
6. Carter RN, Paterson JM, Tworowska U, Stenvers DJ, Mullins JJ, Seckl JR & Holmes MC. 2009 Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11B-HSD1 is strain-dependent. Journal of Neuroendocrinology 21 879-887.
7. Chan ECY, Pasikanti KK & Nicholson JK. 2011 Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nature Protocols 6 1483-1499.
8. Condon J, Ricketts ML, Whorwood CB & Stewart PM. 1997 Ontogeny and sexual dimorphic expression of mouse type 2 11B-hydroxysteroid dehydrogenase. Molecular and Cellular Endocrinology 127 121-128.
9. Cooper MS & Stewart PM. 2009 11B-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. Journal of Clinical Endocrinology and Metabolism 94 4645-4654.
10. Draper N & Stewart PM. 2005 11B-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. Journal of Endocrinology 186 251-271.
11. Gomez-Sanchez EP, Gomez-Sanchez CM, Plonczynski M & Gomez-Sanchez CE. 2010 Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension. Experimental Physiology 95 120-130.
12. Harno E & White A. 2010 Will treating diabetes with 11B-HSD1 inhibitors affect the HPA axis? Trends in Endocrinology and Metabolism 21 619-627.
13. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR & Holmes MC. 2001 Intracellular regeneration of glucocorticoids by 11B-hydroxysteroid dehydrogenase (11B-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11B -HSD-1-deficient mice. Endocrinology 142 114-120.
14. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS et al. 2005 11B-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. Journal of Experimental Medicine. 202 517-527.
15. Hewitt KN, Bujalska IJ, Draper N, Onyimba CU, Walker EA & Stewart PM. 2005 Murine expression of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and hexose-6-phosphate dehydrogenase (H6PDH). Endocrine Abstracts 9 18.
16. Idkowiak J, Lavery GG, Dhir V, Barrett TG, Stewart PM, Krone N & Arlt W. 2011 Premature adrenarche: novel lessons from early onset androgen excess. European Journal of Endocrinology 165 189-207.
17. Krone N, Riepe FG, Grotzinger J, Partsch CJ & Sippell WG. 2005 Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 90 445-454.
18. Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W & Shackleton CHL. 2010 Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). Journal of Steroid Biochemistry and Molecular Biology 121 496-504.
19. Lavery GG. 2007 Hexose-6-phosphate dehydrogenase: a novel regulator of glucocorticoid hormone action. Endocrine Abstracts 13 OC5.
20. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CHL, Parker KL, White PC & Stewart PM. 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11B-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. Journal of Biological Chemistry 281 6546-6551.
21. Lavery GG, Hauton D, Hewitt KN, Brice SM, Sherlock M, Walker EA & Stewart PM. 2007 Hypoglycemia with enhanced hepatic glycogen synthesis in recombinant mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 148 6100-6106.
22. Lavery GG,Walker EA, Tiganescu A, Ride JP, ShackletonCHL, Tomlinson JW, Connell JMC, Ray DW, Biason-Lauber A, Malunowicz EM et al. 2008a Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. Journal of Clinical Endocrinology and Metabolism 10 3827-3832.
23. Lavery GG, Walker EA, Turan N, Rogoff D, Ryder JW, Shelton JM, Richardson JA, Falciani F, White PC, Stewart PM et al. 2008b Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. Journal of Biological Chemistry 283 8453-8461.
24. Lawson AJ, Walker EA, Lavery GG, Bujalska IJ, Hughes B, Arlt W, Stewart PM & Ride JP. 2011 Cortisone-reductase deficiency associated with heterozygous mutations in 11B-hydroxysteroid dehydrogenase type 1. PNAS 108 4111-4116.
25. Low SC, Assaad SN, Rajan V, Chapman KE, Edwards CRW& Seckl JR. 1993 Regulation of 11B-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. Journal of Endocrinology 139 27-35.
26. Odermatt A, Arnold P, Stauffer A, Frey BM & Frey FJ. 1999 The N-terminal anchor sequences of 11B-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. Journal of Biological Chemistry 274 28762-28770.
27. Rogoff D, Ryder JW, Black K, Yan Z, Burgess S, McMillan DR & White PC. 2007 Abnormalities of glucose homeostasis and the hypothalamic- pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 148 5072-5080.
28. Semjonous N, Hughes B, Walker E, Lavery G & Stewart P. 2010 Urinary steroid metabolite profiling in 11B-HSD1 and H6PDH transgenic mice. Endocrine Abstracts 21 349.
29. Semjonous NM, Sherlock M, Jeyasuria P, Parker KL,Walker EA, Stewart PM & Lavery GG. 2011 Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11-B hydroxysteroid dehydrogenase type 1. Endocrinology 152 93-102.
30. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M & Stewart PM. 1998 11-β Hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Human Reproduction 13 799-804.
31. Tomlinson JW & Stewart PM. 2005 Adrenal gland (including endocrine hypertension): mechanisms of disease: selective inhibition of 11B-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome. Nature Reviews. Endocrinology 1 92-99.
32. Toogood AA, Taylor NF, Shalet SM & Monson JP. 2000 Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent. Clinical Endocrinology 52 61-66.
33. Zhang Y, Zhong X, Gjoka Z, Li Y, Stochaj W, Stahl M, Kriz R, Tobin JF, Erbe D & Suri V. 2009 H6PDH interacts directly with 11B-HSD1: implications for determining the directionality of glucocorticoid catalysis. Archives of Biochemistry and Biophysics 483 45-54.
34. Zielinska AE, Walker EA, Stewart PM & Lavery GG. 2011 Biochemistry and physiology of hexose-6-phosphate dehydrogenase knock out mice. Molecular and Cellular Endocrinology 336 213-218.